The goal of this online program is to introduce clinicians to health economics principles that will enable them to describe the value of different antihyperglycemic agents in providing glycemic control and cardiovascular protection. It will also encourage clinicians to recognize the need for early and intensive treatment of type 2 diabetes to reduce the risk of complications and to reduce costs.
This program is supported in part by an educational grant from: Novo Nordisk Saudi Arabia
Dr. Marc Evans, MB, Bch, FRCP (UK), MD (Wales)
Dr. David Strain, MB, ChB, BSc (Hons) MD, FRCP
This program is accredited by the Saudi Commission for Health Specialties for 2 CPD hours.
Credits are reported to the Saudi Commission for Health Specialties on a monthly basis. Please ensure that your Saudi Commission Classification ID is accurate in your MDBriefCase profile and allow sufficient time for credits to appear in your Mustamir account.
Upon completion of this program, participants will be able to: